New board of the Lower Austrian health agency: Zens remains in the service of the patient!

New board of the Lower Austrian health agency: Zens remains in the service of the patient!

Niederösterreich, Österreich - Alfred Zens leaves the Lower Austrian State Health Agency (Lower Austria LGA) to take on a new position at MedaUtron. Since April 2022, Zens worked as part of the leadership trio in the Lower Austrian LGA, which also includes the board members Konrad Kogler and Elisabeth Brütigam. His responsibilities included the five health regions, research, innovation, facility management and finance. The Chairman of the Supervisory Board of the Lower Austrian LGA, Susanne Höllinger, praised his earnings for the new structure of the agency and emphasized that Zens also preserved the health sector in Lower Austria in his new role. This revision of the management team is considered important by State Councilor Ludwig Schleritzko (ÖVP) to ensure the continuation of health care at a high level, the NÖN

New chapter for Zens

By moving away from the Lower Austrian LGA on April 1, 2024, Zens became the official board of Medausttron. This follows the departure of Helmut Krenn, who will retire after almost 50 years in healthcare. In his new role, Zens, an experienced specialist, will take responsibility for the control of the clinics and care centers in Lower Austria. When he presented his inaugural speech, he emphasized the high quality of the Austrian health system and announced that he would continue to contribute to its strengthening. According to noe.gv.at expects the governor Johanna Mikl-Leitner that Zens will bring fresh wind into the organization with his rich horizon is.

Alfred Zens ’professional career is impressive. After studying electrical engineering and biomedicine, he started as a technical director in the Ried hospital in the Innkreis. He held various management positions, including as managing director at Medaustron, and thus brings a wealth of experience into his new role. He also has academic degrees, including an MBA, which makes him a qualified manager in the health sector. Its movement to MedaUtron could mean significant impulses for further development in medical research and technology that are of great importance in the region.